Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CAG vs GSK✓SelectedUSD · GSKCAG vs GSK performance historyLatest closeAs of+1.09%11/18
Stock and ETF performance explorer

CAG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-38.3%
GSK return
+42.7%
Excess return
-81.0%
Maximum drawdown
-62.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.1%-1.3%+2.4%+1.5%
7D0.0%-3.1%+3.1%+0.9%
30D+6.9%-0.9%+7.8%+7.3%
3M-3.3%-4.2%+0.8%-2.3%
6M+10.0%-1.6%+11.6%+10.4%
YTD-8.4%+2.6%-11.0%-9.4%
1Y-8.7%+6.2%-14.9%-10.5%
3Y-36.9%+55.0%-91.9%-44.1%
5Y-38.3%+42.8%-81.1%-43.9%
All-38.3%+42.7%-81.0%-43.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling